Skip to main content
Clinical Trials/NL-OMON27967
NL-OMON27967
Completed
Not Applicable

The effect of enhanced prism spectacles on Quality of Life in patients with severe macular degeneration, a Randomized Controlled Trial.

Erasmus Medical Center0 sites160 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients experiencing severe irreversible vision loss as a result of age-related macular degeneration (ARMD)
Sponsor
Erasmus Medical Center
Enrollment
160
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Visser MS, Dieleman M, Klijn S, Timman R, Lundström M, Busschbach JJV & Reus NJ. Validation, test-retest reliability and norm scores for the Dutch Catquest-9SF. Acta Ophthalm. 2016;Oct 24. doi: 10.1111/aos.13287.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • diagnosis of age\-related macular degeneration (AMD)
  • \- aged at least 18 years

Exclusion Criteria

  • \- insufficient capacities of the Dutch language
  • \- handicaps impeding participation

Outcomes

Primary Outcomes

Not specified

Similar Trials